跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SALONPAS - PLS TOP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SALONPAS - PLS TOP
Authorized
STANDARD
SALONPAS - PLS TOP
Hisamitsu Pharmaceutical Co., Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
71d5caab48938343
Company
Hisamitsu Pharmaceutical Co., Inc.
Type
Standard
Approval Details
Approval Id
71d5caab48938343
Drug Approval Canada Name
SALONPAS - PLS TOP
Product Name
SALONPAS - PLS TOP
Status
Cancelled Post Market
Status Date
2003-11-04
Original Market Date
1995-08-03
Din
02179520
Drug Class
Human
Dosage Form
Plaster
Route Of Administration
Topical
Schedule
OTC
Ahfs
28:08.04.24
Atc Original
M02AC PREPARATIONS WITH SALICYLIC ACID DERIVATIVES
Atc Name
m 02 ac
Aig Number
0527408001
Company Name
Hisamitsu Pharmaceutical Co., Inc.
Company Address
2-4-1 Marunouchi, Chiyoda-Ku, Tokyo-To, Japan, 100-6330
Company Detail Path
/organization/hisamitsu-pharmaceutical-co-inc
Company Information
Pharmaceutical Company Name
Hisamitsu Pharmaceutical Co., Inc.
Country Name
Japan
Province Name
佐贺县
City Name
佐贺县鸟栖市
Website
http://www.hisamitsu.co.jp
Active Ingredients
LEVOMENTHOL
5.7 %
GLYCOL SALICYLATE
.9 %
THYMOL
.8 %
CAMPHOR
1.2 %
METHYL SALICYLATE
6.2 %
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
71d5caab48938343
Type
Standard
Back to Health Canada Approvals